Effects of flurbiprofen and flurbinitroxybutylester on prostaglandin endoperoxide synthases

European Journal of Pharmacology

Volumn 316, Issue 1, 1996, Pages 65-72

  Santini, Giovanna ^a   Sciulli, Maria G ^a   Panara, Maria R ^a   Padovano, Roberto ^a   Di Giamberardino, Maria ^a   Rotondo, Maria T ^a   Del Soldato, Piero ^b   Patrignani, Paola ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b NICOX Ltd   (United Kingdom)

Author keywords

Blood monocyte; Flurbinitroxybutylester; Flurbiprofen; Human; Platelet; Prostaglandin endoperoxide synthase

Indexed keywords

ACETYLSALICYLIC ACID; FLURBIPROFEN; ISOENZYME; PROSTAGLANDIN SYNTHASE;

ARTICLE; BLOOD; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; MALE; MONOCYTE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PLATELETS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DRUG STABILITY; FEMALE; FLURBIPROFEN; HUMANS; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; THROMBOXANE B2;

EID: 0030605218     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00640-1     Document Type: Article

References (34)

1. Barnett, J., J. Chow, D. Ives, M. Chiou, R. Mackenzie, E. Osen, B. Nguien, S. Tsing, C. Bach, J. Freire, H. Chan, E, Sigal and C. Ramesha, 1994, Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system, Biochim. Biophys. Acta 1209, 130.
2. Bateman, D.N., 1996, Re-evaluation of gut toxicity of NSAIDs, in: Improved Non-Steroid Anti-Inflammatory Drugs, COX-2 Enzyme Inhibitors, eds. J. Vane, J. Botting and R. Botting (Kluwer and William Harvey) p. 189.
3. Boyum, A., 1968, Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at I g, Scand. J. Clin. Lab. Invest. 97, 77.
4. Chan, C.-C., S. Boyce, C. Brideau, A.W. Ford-Hutchinson, R. Gordon, D. Guay, R.G. Hill, C.-S. Li, J. Mancini, M. Penneton, P. Prasit, R. Rasori, D. Riendeau, P. Roy, P. Tagari, P. Vickers, E. Wong and I.W. Rodger, 1995, Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach, J. Pharmacol. Exp. Ther. 274, 1531.
5. 2α in human urine, J. Endocrinol. Invest. 2, 173.
6. De Lean, A., P.J. Munson and D. Rodbard, 1978, Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235, E97.
7. Grossman, C.J., J. Wiseman, F.S. Lucas, M.A. Trevethick and P.J. Birch, 1995, Inhibition of constitutive and inducible cylooxygenase activity in human platelets and mononuclear cells by NSAIDS and COX 2 inhibitors. InfLamm. Res. 44, 253.
8. Habib, A., C. Créminon, Y. Frobert, J. Grassi, P. Pradelles and J. Maclouf, 1993, Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxylterminal region of the cyclooxygenase-2, J. Biol. Chem. 268, 23448.
9. Hla, T. and K. Neilson, 1992, Human cyclooxygenase-2 cDNA, Proc. Natl. Acad. Sci. USA 89, 7384.
10. Jones, D.A., D.P. Carlton, T.M. McIntyre, G.A. Zimmerman and S.M. Prescott, 1993, Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines, J. Biol. Chem. 268, 9049.
11. Kitagawa, H., F. Takeda and H. Kohei, 1990, Effects of endotelium-derived relaxing factor on the gastric lesion induced by HCl in rats, J. Pharmacol. Exp. Ther. 253, 1133.
12. Kraemer, S.A., E.A. Meade and D.L. DeWitt, 1992, Prostaglandin endoperoxide synthase gene structure: identification of the trascriptional start site and 5′-flanking regulatory sequences, Arch. Biochem. Biophys. 293, 391.
13. Kujubu, D.A. and H.R. Herschman, 1992, Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene, J. Biol. Chem. 267, 7991.
14. Laneuville, O., D.K. Breuer, D.L. DeWitt, T. Hla, C.D. Funk and W.L. Smith, 1994, Differential inhibition of human prostaglandin endoperoxide H synthase-1 and -2 by nonsteroidal anti-inflammatory drugs, J. Pharmacol. Exp. Ther. 271, 927.
15. Lopez-Belmonte, J., B.J. Whittle and S. Moncada, 1993, The action of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa, Br. J. Pharmacol. 108, 73.
16. MacNaughton, W.K., G. Cirino and J.L. Wallace, 1989, Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach, Life Sci. 45, 1869.
17. Masferrer, J.L., B.S. Zweifel, P.T. Manning, S.D. Hauser, K.M. Leahy, W.G. Smith, P.C. Isakson and K. Seibert, 1994. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic, Proc. Natl. Acad. Sci. USA 91, 3228.
18. Mitchell, J.A., P. Akarasereenont, C. Thiemermann, R.J. Flower and J.R. Vane, 1993, Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase, Proc. Natl. Acad. Sci. USA 90, 11693.
19. Mitchell, J.A., G. Cirino, P. Akarasereenont, J.L. Wallace, R.J. Flower and J.R. Vane, 1994, Flurbinitroxybutylester, a novel anti-inflammatory drug devoid of ulcerogenic activity, inhibits cyclo-oxygenase-1 and cyclo-oxygenase-2, Can. J. Physiol. Pharmacol. 72 (Suppl. 1), 270 (Abstract).
20. O'Banion, M.K., H.B. Sadowski, V. Winn and D.A. Young, 1991, A serum and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase related protein, J. Biol. Chem. 266, 23261.
21. Panara, M.R., A. Greco, G. Santini, M.G. Sciulli, M.T. Rotondo, R. Padovano, M. di Giamberardino, F. Cipollone, F. Cuccurullo, C. Patrono and P. Patrignani, 1995, Effects of the novel anti-inflammatory compounds. N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothiphenyl)-1-indanone (L-745,337), on the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases, Br. J. Pharmacol. 116, 2429.
22. Patrignani, P., M.R. Panara, A, Greco, O. Fusco, C. Natoli, S. Iacobelli, F. Cipollone, A. Ganci, C. Crèminon, J. Maclouf and C. Patrono, 1994, Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases, J. Pharmacol. Exp. Ther. 271, 1705.
23. 2 production in healthy subjects, Thromb. Res. 17, 317.
24. 2 synthase-1, Nature 367, 243.
25. Salvemini, D., T.P. Misko, J.L. Masferrer, K. Seibert, M.G. Currie and P. Needleman, 1993, Nitric oxide activates cyclooxygenase enzymes, Proc. Natl. Acad. Sci. USA 90, 7240.
26. Seibert, K., Y. Zhang, K. Leahy, S. Hauser, J. Masferrer, W. Perkins, L. Lee and P, Isakson, 1994, Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain, Proc. Natl. Acad. Sci. USA 91, 12013.
27. Smith, W.L. and D.L. DeWitt, 1995, Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal antiinflammatory drugs, Semin. Nephrol. 15, 179.
28. Soll, A.H., W.M. Weinstein, J. Kurata and D. McCarthy, 1991, Nonsteroidal anti-inflammatory drugs and peptic ulcer disease, Ann. Intern. Med. 114, 307.
29. Stadler, J., B.G. Harbrecht, M. Di Silvio, R.D. Curran, R.D. Jordan, M.L. Simmons and T.R. Billiar, 1993, Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells, J. Leukocyte Biol. 53, 165.
30. Vane, J.R. and R.M. Bolting, 1995, New insights into the mode of action of anti-inflammatory drugs, Inflamm. Res. 44, 1.
31. Vane, J.R., J.A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall and D.A. Willoughby, 1994. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation, Proc. Natl. Acad. Sci. USA 91, 2046.
32. Wallace, J.L. and G. Cirino, 1994, The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs, Trends Pharmacol. Sci. 15, 405.
33. Wallace, J.L., B. Reuter, C. Cicala, W. Mcknight, M.B. Grisham and G. Cirino, 1994a, Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat, Gastroenterology 107, 173.
34. Wallace, J.L., B. Reuter, C. Cicala, W. McKnight, M. Grisham and G.L. Cirino, 1994b, A diclofenac derivative without ulcerogenic properties, Eur. J. Pharmacol. 257, 249.